Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.

Twenty-six human immunodeficiency virus (HIV)-infected asymptomatic patients with CD4+ lymphocytes > 400 per mm3 were randomly allocated to a range of doses of recombinant gp160 or a control (recombinant hepatitis B vaccine) on a double-blind basis. Each patient received an injection at 0, 4, 12, 24...

Volledige beschrijving

Bibliografische gegevens

Gepubliceerd in:	Proc Natl Acad Sci U S A
Hoofdauteurs:	Kundu, S K, Katzenstein, D, Moses, L E, Merigan, T C
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	National Academy of Sciences 1992
Onderwerpen:	Research Article
Online toegang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC50518/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1360665/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.89.23.11204
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!